April 15, 2025

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention:

Mitchell Austin

 

 

Re:

Ekso Bionics Holdings, Inc.

Registration Statement on Form S-3

File No. 333-286463

Filed on April 10, 2025

 

Acceleration Request

 

Requested Date:           April 17, 2025

Requested Time:          4:30 p.m. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-286463) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.

 

 

Sincerely, 

   
  EKSO BIONICS HOLDINGS, INC.

 

 

 

 

 

 

 

By:

/s/ Scott G. Davis

 

 

Scott G. Davis 

 

 

Chief Executive Officer 

 

 

cc:

Mark B. Baudler, Wilson Sonsini Goodrich & Rosati

Austin D. March, Wilson Sonsini Goodrich & Rosati